Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia

British Journal of Psychiatry

Volumn 200, Issue 4, 2012, Pages 300-307

  Bodnar, Michael ^a,b   Achim, Amelie M ^a,b   Malla, Ashok K ^a,b   Joober, Ridha ^a,b   Benoit, Audrey ^a   Lepage, Martin ^a,b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MEMORY CONSOLIDATION; POSTERIOR CINGULATE; REMISSION; SCHIZOPHRENIA; SEMANTIC MEMORY;

ADULT; CASE-CONTROL STUDIES; FEMALE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MEMORY DISORDERS; SCHIZOPHRENIA; TEMPORAL LOBE; YOUNG ADULT;

EID: 84859600587     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.098046     Document Type: Article

References (40)

1. Cirillo MA, Seidman LJ. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev 2003; 13: 43-77. (Pubitemid 38113372)
2. Ragland JD, Laird AR, Ranganath C, Blumenfeld RS, Gonzales SM, Glahn DC. Prefrontal activation deficits during episodic memory in schizophrenia. Am J Psychiatry 2009; 166: 863-74.
3. Achim AM, Lepage M. Episodic memory-related activation in schizophrenia: meta-analysis. Br J Psychiatry 2005; 187: 500-9. (Pubitemid 41752738)
4. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153: 321-30. (Pubitemid 26074706)
5. Bodnar M, Harvey P-O, Malla A, Joober R, Lepage M. The parahippocampal gyrus as a neural marker of early remission in first episode psychosis: a voxel-based morphometry study. Clin Schizophr Relat Psychoses 2011; 4: 217-28.
6. Bodnar M, Malla A, Joober R, Lepage M. Cognitive markers of short-term clinical outcome in first-episode psychosis. Br J Psychiatry 2008; 193: 297-304.
7. Helldin L, Kane JM, Karilampi U, Norlander T, Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res 2006; 40: 738-45. (Pubitemid 44486248)
8. Toulopoulou T, Murray RM. Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Rev Neurother 2004; 4: 43-52. (Pubitemid 38082122)
9. McGuire P, Howes OD, Stone J, Fusar-Poli P. Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci 2008; 29: 91-8.
10. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, et al. Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry 1991; 48: 618-24.
11. Hyman SE, Fenton WS. Medicine. What are the right targets for psychopharmacology? Science 2003; 299: 350-1.
12. Ranganath C, Minzenberg MJ, Ragland JD. The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol Psychiatry 2008; 64: 18-25.
13. Andreasen NC, Carpenter Jr WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-9. (Pubitemid 40343909)
14. Achim AM, Bertrand MC, Montoya A, Malla AK, Lepage M. Medial temporal lobe activations during associative memory encoding for arbitrary and semantically related object pairs. Brain Res 2007; 1161: 46-55. (Pubitemid 47068419)
15. Achim AM, Bertrand MC, Sutton H, Montoya A, Czechowska Y, Malla AK, et al. Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. Arch Gen Psychiatry 2007; 64: 999-1014. (Pubitemid 47360845)
16. Bodnar M, Malla AK, Czechowska Y, Benoit A, Fathalli F, Joober R, et al. Neural markers of remission in first-episode schizophrenia: a volumetric neuroimaging study of the hippocampus and amygdala. Schizophr Res 2010; 122: 72-80.
17. Malla A, Norman R, McLean T, Scholten D, Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Aust N Z J Psychiatry 2003; 37: 407-13. (Pubitemid 37121573)
18. Kay S, Fiszbein A, Opler L. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76. (Pubitemid 18039085)
19. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P & SCID-I/NP), Version 2. New York Psychiatric Institute, Biometrics Research, 1998.
20. Slotnick SD, Moo LR, Segal JB, Hart Jr J. Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes. Brain Res Cogn Brain Res 2003; 17: 75-82. (Pubitemid 36577543)
21. Slotnick SD, Schacter DL. A sensory signature that distinguishes true from false memories. Nat Neurosci 2004; 7: 664-72. (Pubitemid 38691907)
22. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med 1995; 33: 636-47.
23. Petersson KM, Nichols TE, Poline JB, Holmes AP. Statistical limitations in functional neuroimaging. II. Signal detection and statistical inference. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1261-81. (Pubitemid 29400905)
24. Snodgrass JG, Corwin J. Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol Gen 1988; 117: 34-50.
25. Wechsler D. Wechsler Adult Intelligence Scale (3rd edn). The Psychological Corporation, 1997.
26. Wang K, Cheung EF, Gong QY, Chan RC. Semantic processing disturbance in patients with schizophrenia: a meta-analysis of the n400 component. PLoS One 2011; 6: e25435.
27. Doughty OJ, Done DJ. Is semantic memory impaired in schizophrenia? A systematic review and meta-analysis of 91 studies. Cogn Neuropsychiatry 2009; 14: 473-509.
28. Binder JR, Desai RH, Graves WW, Conant LL. Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies. Cereb Cortex 2009; 19: 2767-96.
29. Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci USA 2009; 106: 1279-84.
30. Meda SA, Stevens MC, Folley BS, Calhoun VD, Pearlson GD. Evidence for anomalous network connectivity during working memory encoding in schizophrenia: an ICA based analysis. PLoS One 2009; 4: e7911.
31. Garrity AG, Pearlson GD, McKiernan K, Lloyd D, Kiehl KA, Calhoun VD. Aberrant "default mode" functional connectivity in schizophrenia. Am J Psychiatry 2007; 164: 450-7. (Pubitemid 46513159)
32. Broyd SJ, Demanuele C, Debener S, Helps SK, James CJ, Sonuga-Barke EJ. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev 2009; 33: 279-96.
33. Wang L, Laviolette P, O'Keefe K, Putcha D, Bakkour A, Van Dijk KR, et al. Intrinsic connectivity between the hippocampus and posteromedial cortex predicts memory performance in cognitively intact older individuals. Neuroimage 2010; 51: 910-7.
34. Ramsey NF, Jansma JM, Jager G, Van Raalten T, Kahn RS. Neurophysiological factors in human information processing capacity. Brain 2004; 127: 517-25. (Pubitemid 38295469)
35. Honey G, Bullmore E. Human pharmacological MRI. Trends Pharmacol Sci 2004; 25: 366-74. (Pubitemid 38829490)
36. Stein EA. fMRI: a new tool for the in vivo localization of drug actions in the brain. J Anal Toxicol 2001; 25: 419-24. (Pubitemid 32656297)
37. Newell KA, Zavitsanou K, Huang XF. Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients. Neuroreport 2005; 16: 1363-7. (Pubitemid 41225211)
38. Newell KA, Zavitsanou K, Jew SK, Huang XF. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 225-33. (Pubitemid 44959255)
39. Abbott C, Juarez M, White T, Gollub RL, Pearlson GD, Bustillo J, et al. Antipsychotic dose and diminished neural modulation: a multi-site fMRI study. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 473-82.
40. Ettinger U, Williams SC, Fannon D, Premkumar P, Kuipers E, Moller HJ, et al. Functional magnetic resonance imaging of a parametric working memory task in schizophrenia: relationship with performance and effects of antipsychotic treatment. Psychopharmacology (Berl) 2011; 216: 17-27.